Cellerant Therapeutics cellerant.com


Public list: Pharma Startups (4740) Cancer Therapeutics (1146)

Cellerant Therapeutics is a clinical stage biotechnology company focused on the regulation of the hematopoietic (blood-forming) system. The Company is developing human stem cell and antibody therapies for oncology applications and blood-related disorders. Cellerant's lead product, CLT-008 is currently in two Phase 1 clinical trials in patients with hematological malignancies. The Company also has a Cancer Stem Cell (CSC) antibody discovery program focused on therapies for acute myeloid leukemia,...Show all

Cellerant Therapeutics is a clinical stage biotechnology company focused on the regulation of the hematopoietic (blood-forming) system. The Company is developing human stem cell and antibody therapies for oncology applications and blood-related disor...Show all

Company (Alive / Active)

Phone: 650-232-2122

Fax:

1561 Industrial Road

San Carlos, 94070
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Cellerant Therapeutics $81.2M Apr 13, 2016
See all 21 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Cellerant Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 21 investors

Competitors

Company Status Description Investors
See all 21 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Isoquinolidinobenzodiazepines Oct 26, 2016 May 22, 2018 Patent
Antibodies specific for cll-1 Sep 14, 2015 Dec 26, 2017 Patent
Antibodies that specifically bind to tim3 Aug 12, 2014 Apr 25, 2017 Patent
Isoquinolidinobenzodiazepines Feb 19, 2016 Nov 29, 2016 Patent
Cytokine receptors associated with myelogenous haematological proliferative disorders and uses thereof Apr 03, 2014 Jun 21, 2016 Patent
See all 14 patents